Theravance Biopharma Inc Financial Flexibility Index
Theravance Biopharma Inc financial flexibility index. Theravance Biopharma Inc (TBPH) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of $-6.06 Million (operating CF $-6.06 Million minus capex $8.00K) represents 0% of total liabilities ($188.85 Million). See Theravance Biopharma Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Theravance Biopharma Inc (2011–2025)
Financial flexibility index of Theravance Biopharma Inc from 2011 to 2025. Historical Financial Flexibility Index trend for Theravance Biopharma Inc across 15 annual periods. Check how high is Theravance Biopharma Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Theravance Biopharma Inc Financial Flexibility Index by Year (2011–2025)
Theravance Biopharma Inc financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Theravance Biopharma Inc. For the full cash flow conversion analysis, see cash flow conversion of Theravance Biopharma Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.26x | $238.58 Million | $238.54 Million | $188.85 Million | ▲ +2114.3% |
| 2024 | -0.06x | $-11.20 Million | $-11.54 Million | $178.62 Million | ▲ +56.8% |
| 2023 | -0.15x | $-24.51 Million | $-27.00 Million | $169.00 Million | ▲ +87.1% |
| 2022 | -1.13x | $-186.42 Million | $-186.99 Million | $165.60 Million | ▼ -292.8% |
| 2021 | -0.29x | $-204.45 Million | $-207.86 Million | $713.39 Million | ▲ +9.2% |
| 2020 | -0.32x | $-243.79 Million | $-250.40 Million | $772.81 Million | ▲ +15.1% |
| 2019 | -0.37x | $-235.02 Million | $-238.20 Million | $632.67 Million | ▼ -115.2% |
| 2018 | -0.17x | $-105.63 Million | $-112.87 Million | $611.82 Million | ▲ +71.6% |
| 2017 | -0.61x | $-198.65 Million | $-201.05 Million | $326.22 Million | ▼ -81.7% |
| 2016 | -0.34x | $-96.85 Million | $-98.99 Million | $289.02 Million | ▲ +88.5% |
| 2015 | -2.91x | $-166.21 Million | $-168.86 Million | $57.05 Million | ▲ +18.7% |
| 2014 | -3.59x | $-172.05 Million | $-175.16 Million | $47.98 Million | ▼ -28.0% |
| 2013 | -2.80x | $-118.22 Million | $-120.96 Million | $42.21 Million | ▲ +45.5% |
| 2012 | -5.14x | $-116.52 Million | $-119.11 Million | $22.67 Million | ▼ -895.3% |
| 2011 | -0.52x | $-79.80 Million | $-83.43 Million | $154.54 Million | — |